相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
Shiva Bamezai et al.
LEUKEMIA (2021)
A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase-Deficient Cells in Myeloid Neoplasms
Yihong Guan et al.
BLOOD CANCER DISCOVERY (2021)
The roles of TET family proteins in development and stem cells
Jihong Yang et al.
DEVELOPMENT (2020)
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients
Giacomo Coltro et al.
LEUKEMIA (2020)
Selective targeting of TET catalytic domain promotes somatic cell reprogramming
Anup Kumar Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion
Shuang Yu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Distinct and stage-specific contributions of TET1 and TET2 to stepwise cytosine oxidation in the transition from naive to primed pluripotency
Christopher B. Mulholland et al.
SCIENTIFIC REPORTS (2020)
Cytosine-Based TET Enzyme Inhibitors
Gabriella N. L. Chua et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma
Maria Prates Rivas et al.
FRONTIERS IN GENETICS (2019)
Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Yan-ping Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells
Jian Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas
Francois Lemonnier et al.
HAEMATOLOGICA (2018)
Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas
Francois Lemonnier et al.
HAEMATOLOGICA (2018)
Epigenetic drug discovery: a success story for cofactor interference
A. Ganesan
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Maintenance DNA Methyltransferase Activity in the Presence of Oxidized Forms of 5-Methylcytosine: Structural Basis for Ten Eleven Translocation-Mediated DNA Demethylation
Christopher L. Seiler et al.
BIOCHEMISTRY (2018)
Whole genome DNA methylation: beyond genes silencing
Roberto Tirado-Magallanes et al.
ONCOTARGET (2017)
Copper Inhibits the AlkB Family DNA Repair Enzymes under Wilson's Disease Condition
Ke Bian et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
How to Triage PAINS-Full Research
Jayme L. Dahlin et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis
Min-Zu Wu et al.
CANCER RESEARCH (2015)
Structural insight into substrate preference for TET- mediated oxidation
Lulu Hu et al.
NATURE (2015)
TET proteins and 5-methylcytosine oxidation in hematological cancers
Myunggon Ko et al.
IMMUNOLOGICAL REVIEWS (2015)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion
Kar Kheng Yeoh et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
TET1 plays an essential oncogenic role in MLL-rearranged leukemia
Hao Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
DNA glycosylases: in DNA repair and beyond
Angelika L. Jacobs et al.
CHROMOSOMA (2012)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
Wen-Chien Chou et al.
BLOOD (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Inhibition of 2-oxoglutarate dependent oxygenases
Nathan R. Rose et al.
CHEMICAL SOCIETY REVIEWS (2011)
Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation
Hao Wu et al.
GENES & DEVELOPMENT (2011)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko et al.
NATURE (2010)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Replacement of non-heme Fe(II) with Cu(II) in the α-ketoglutarate dependent DNA repair enzyme AlkB:: Spectroscopic characterization of the active site
Boris Bleijlevens et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins
Ian J. Clifton et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase
DR Mole et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
分享论文
